The prevalence of HPV among 164,137 women in China exhibited some unique epidemiological characteristics.

Cervical cancer High-risk HPV Human papillomavirus

Journal

Infectious agents and cancer
ISSN: 1750-9378
Titre abrégé: Infect Agent Cancer
Pays: England
ID NLM: 101276559

Informations de publication

Date de publication:
10 Nov 2023
Historique:
received: 27 05 2023
accepted: 03 11 2023
medline: 11 11 2023
pubmed: 11 11 2023
entrez: 11 11 2023
Statut: epublish

Résumé

The persistence of HPV infection is a significant etiological factor in the development of cervical cancer. The present study investigated the prevalence and genotype distribution of human papillomavirus (HPV) in a cohort of 164,137 unvaccinated women from Wenzhou, aiming to provide guidance for clinics in the cervical cancer screening and HPV vaccination strategies. The present retrospective study included a total of 164,137 women, comprising 118,484 outpatients and 45,653 healthy female subjects recruited from 2015 to 2020. Cervical exfoliated cells were collected from these participants for subsequent DNA extraction. The extracted DNA samples were underwent analysis using a fluorescence in situ hybridization method, encompassing the detection of 27 HPV genotypes. The overall prevalence of HPV was 17.35%; this corresponded to a prevalence of 19.10% in the outpatient group and 12.82% in the healthy female group. Among the outpatient group, the five most prevalent HPV genotypes were identified as HPV 52, 58, 16, 53, and 61. In the healthy female group, the five most common HPV genotypes were found to be HPV 52, 53, 58, 61, and 81. Additionally, it was estimated that the highest rate of HPV infection occurred among individuals aged between 10 and 19 years old (44.65%) and those aged between 60 and 69 years old (27.35%). The prevalence of HPV in this region is substantial; therefore, it is imperative to implement scientifically sound and rational clinical interventions such as vaccination. Routine cervical screening should be performed to prevent the development of cervical intraepithelial neoplasia resulting from persistent infection with high-risk HPV, particularly in women with gynecological diseases and those over 60 years old.

Identifiants

pubmed: 37950328
doi: 10.1186/s13027-023-00553-4
pii: 10.1186/s13027-023-00553-4
pmc: PMC10638728
doi:

Types de publication

Journal Article

Langues

eng

Pagination

72

Subventions

Organisme : The present study was funded by the Medical health Science and Technology Project of Zhejiang Province
ID : 2018262494

Informations de copyright

© 2023. The Author(s).

Références

BMC Public Health. 2017 Aug 3;18(1):95
pubmed: 28774274
Cells. 2019 Jun 21;8(6):
pubmed: 31234354
Biology (Basel). 2021 Aug 18;10(8):
pubmed: 34440026
Asian Pac J Cancer Prev. 2014;15(17):7333-6
pubmed: 25227838
Arch Gynecol Obstet. 2023 Jul;308(1):35-41
pubmed: 35904609
Infect Drug Resist. 2021 Oct 10;14:4173-4182
pubmed: 34675562
Trans R Soc Trop Med Hyg. 2021 Jan 7;115(1):30-37
pubmed: 32838408
Int J Infect Dis. 2021 Aug;109:8-16
pubmed: 34111543
BMC Infect Dis. 2018 May 3;18(1):204
pubmed: 29724192
J Clin Epidemiol. 2021 Nov;139:319-329
pubmed: 34161804
Sci Rep. 2017 Nov 1;7(1):14813
pubmed: 29093458
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:98-108
pubmed: 32291178
Infect Dis Clin North Am. 2013 Dec;27(4):765-78
pubmed: 24275269
Trans R Soc Trop Med Hyg. 2022 Feb 1;116(2):173-178
pubmed: 34263317
Virol J. 2020 Jun 26;17(1):84
pubmed: 32586352
J Manag Care Pharm. 2010 Apr;16(3):217-30
pubmed: 20331326
Cancer Lett. 2020 Feb 28;471:88-102
pubmed: 31812696
Infect Agent Cancer. 2022 Apr 21;17(1):19
pubmed: 35449004
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Infect Agent Cancer. 2019 Oct 26;14:29
pubmed: 31673281
Cancer. 2019 Apr 1;125(7):1030-1037
pubmed: 30748006
J Infect Public Health. 2017 Nov - Dec;10(6):783-788
pubmed: 28214188
Arch Virol. 2014 May;159(5):1027-32
pubmed: 24248257
J Med Virol. 2022 Jun;94(6):2787-2795
pubmed: 34859449
Arch Gynecol Obstet. 2020 Dec;302(6):1329-1337
pubmed: 32914222
Sci Rep. 2022 Aug 3;12(1):13353
pubmed: 35922661
BMC Infect Dis. 2021 Apr 7;21(1):328
pubmed: 33827456
BMC Infect Dis. 2019 May 8;19(1):390
pubmed: 31068141
BMJ. 2021 Feb 5;372:n280
pubmed: 33547094
Front Public Health. 2022 Jul 18;10:922587
pubmed: 35923957

Auteurs

Qiong Chen (Q)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Wanglei Qu (W)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Yu Zhao (Y)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Li Shu (L)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Yi Wang (Y)

Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Xiangnan Chen (X)

Department of Laboratory Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, No. 1111 East Section of Wenzhou Avenue, Longwan District, Wenzhou, Zhejiang, China. nan5645@163.com.

Classifications MeSH